{"name": "Creabilis",
 "permalink": "creabilis",
 "crunchbase_url": "http://www.crunchbase.com/company/creabilis",
 "homepage_url": "http://www.creabilis-sa.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": null,
 "alias_list": "",
 "email_address": "info@creabilis-sa.com",
 "phone_number": "",
 "description": "",
 "created_at": "Mon Mar 15 04:28:00 UTC 2010",
 "updated_at": "Wed Oct 05 02:25:26 UTC 2011",
 "overview": "\u003Cp\u003ECreabilis is an emerging European specialty pharmaceutical company focused on dermatology. Creabilis discovers, develops and commercialises new medicines for a range of skin disorders, - an area of significant unmet medical need and high commercial potential.\u003C/p\u003E\n\n\u003Cp\u003ECreabilis has an exceptional track record in dermatological research and has used this experience to generate a rich pipeline of clinical and pre-clinical drug candidates that the company will market directly or in partnership. The most advanced product is CT327 for the treatment of psoriasis. CT327 will enter Phase II clinical trials in 2009. Creabilis\u0026#8217; pipeline also includes a number of pre-clinical drug candidates arising from its ground breaking drug discovery programmes.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[123,
       104],
      "assets/images/resized/0008/0329/80329v2-max-150x150.png"],
     [[123,
       104],
      "assets/images/resized/0008/0329/80329v2-max-250x250.png"],
     [[123,
       104],
      "assets/images/resized/0008/0329/80329v2-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Eliot",
      "last_name": "Forster",
      "permalink": "eliot-forster",
      "image": null}},
   {"is_past": false,
    "title": "ice President, Head of Finance and Operations",
    "person":
     {"first_name": "Alex",
      "last_name": "Leech",
      "permalink": "alex-leech",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$20M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.creabilis-sa.com/news.php?id=25",
    "source_description": "Creabilis Raises \u00e2\u201a\u00ac15.0M ($20M) in Series B Fundraising Round",
    "raised_amount": 20000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 10,
    "funded_day": 4,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Abbott Biotech Ventures",
         "permalink": "abbott-biotech-ventures",
         "image":
          {"available_sizes":
            [[[150,
               41],
              "assets/images/resized/0023/2409/232409v3-max-150x150.png"],
             [[250,
               68],
              "assets/images/resized/0023/2409/232409v3-max-250x250.png"],
             [[439,
               120],
              "assets/images/resized/0023/2409/232409v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Sofinnova Partners",
         "permalink": "sofinnova-partners",
         "image":
          {"available_sizes":
            [[[150,
               20],
              "assets/images/resized/0004/4451/44451v1-max-150x150.jpg"],
             [[250,
               33],
              "assets/images/resized/0004/4451/44451v1-max-250x250.jpg"],
             [[321,
               43],
              "assets/images/resized/0004/4451/44451v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [{"funding_round":
     {"round_code": "unattributed",
      "source_url": "http://www.prnewswire.com/news-releases/nautilus-biotech-closes-eur84-million-113-million-investment-funding-58859082.html",
      "source_description": "Nautilus Biotech Closes EUR8.4 Million ($11.3 Million) Investment Funding",
      "raised_amount": 11300000.0,
      "raised_currency_code": "USD",
      "funded_year": 2007,
      "funded_month": 4,
      "funded_day": 30,
      "company":
       {"name": "Nautilus Biotech",
        "permalink": "nautilus-biotech",
        "image": null}}}],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "5, Rue JeanMonnet",
    "address2": "",
    "zip_code": "L-2180",
    "city": "",
    "state_code": null,
    "country_code": "LUX",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        97],
       "assets/images/resized/0008/0330/80330v1-max-150x150.jpg"],
      [[250,
        163],
       "assets/images/resized/0008/0330/80330v1-max-250x250.jpg"],
      [[450,
        293],
       "assets/images/resized/0008/0330/80330v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}